Delivery Order SPE2DB25D3404-SPE2DB25FUMMM
Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Venofer 100 mg/5 ml vials (5 ml) to the Defense Logistics Agency (DLA). The $3,751.29 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- The Defense Logistics Agency awarded a delivery order valued at $2,222.42 to AmerisourceBergen Drug Corp for the supply of Venofer 100 mg/5 mL vials on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,907.09. The contract has a period of performance through December 4, 2024 and uses a Firm Fixed Price pricing structure. This contract is not designated as a set-aside and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical product Venofer, a 100 mg/5 ml injectable iron supplement, with a ceiling value of $2,070.58 and a completion date of May 6, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,107.34 firm fixed-price delivery order is for the supply of VENOFER 100 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, designated as SPE2DX, which provides global pharmaceutical support to...
- This federal contract award is for the delivery of VENOFER 100 MG/5 ML VIAL 5ML to the Defense Logistics Agency, a defense agency. The contract has a ceiling value of $6,407.87 and is a firm fixed price delivery order with a completion date of June 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded on June 12, 2025. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,173.07 for the supply of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,000.10, is a delivery order to provide 4567632634 ! INFED 100 MG/2 ML VIAL 2ML medical supplies. The contract has a firm fixed price pricing type and a period of performance through March 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,030.29 firm-fixed-price delivery order is for the supply of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a performance period extending through June 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $17,097.55 with a ceiling of $17,097.55 and an ultimate completion date of October 16, 2024. The contract provides medical supplies, specifically 4565849994 ! INFED 100MG/2ML VI 10S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUMMMDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,001.67, is for the delivery of Venofer 100 mg/5 ml vials. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award does not have a set-aside designation, indicating open competition.
Generated 7/1/25, 7:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 3/14/25 |